References
- Menegatti M, Peyvandi F. Treatment of rare factor deficiencies other than hemophilia. Blood 2019; 133(5): 415–424. doi: 10.1182/blood-2018-06-820738.
- Pikija S, Gampenrieder SP, Millesi K, Pilz, G, Weis, S, Mutzenbach, JS. Factor VII deficiency in major artery occlusion stroke. Am J Hematol 2018; 93: 843–845. doi: 10.1002/ajh.25031.
- Kim SH, Park YS, Kwon KH, Lee JH, Kim KC, Yoo MC. Surgery in patients with congenital factor VII deficiency: A single center experience. Korean J Hematol 2012; 47(4): 281–285. doi: 10.5045/kjh.2012.47.4.281.
- Mahale R, Rathi P, Ginegiri C, Aggarwal R. Factor VII deficiency: A rare case report. Indian J Hematol Blood Transfus 2010; 26: 68–9. doi: 10.1007/s12288-010-0023-5.
- ELShama HA, ELokda SA. Effect of activated recombinant factor VII versus tranexamic acid infusion on bleeding during spine surgery, randomized, controlled, double blinded trial. Egyptian Journal of Anaesthesia 2015; 31(2): 149–153. doi: 10.1016/j.egja.2014.12.009.
- Ingerslev J, Knudsen L, Hvid I, Tange MR, Fredberg U, Sneppen O. Use of recombinant factor VIIa in surgery in factor-VII-deficient patients. Haemophilia 1997; 3(3): 215–218. doi: 10.1046/j.1365-2516.1997.00105.x.
- Tokgoz H, Caliskan U, Lavigne-Lissalde G, Giansily-Blaizot M. Successful prophylactic use of recombinant activated factor VII (rFVIIa) in a patient with congenital FVII deficiency and inhibitors to FVII. Haemophilia 2012; 18(1): e25–7. doi: 10.1111/j.1365-2516.2011.02666.x.
- Şenol BK, Zülfikar B. Clinical problems and surgical interventions in inherited factor VII deficiency. Turk Pediatri Ars 2020; 55(2): 184–190. doi: 10.14744/TurkPediatriArs.2020.79069.
- Nicolaisen EM. Antigenicity of activated recombinant factor VII followed through nine years of clinical experience. Blood Coagul Fibrinolysis 1998; 9 Suppl 1: S119–23.
- Shams M, Dorgalaleh A, Safarian N, et al. Inhibitor development in patients with congenital factor VII deficiency, a study on 50 Iranian patients. Blood Coagul Fibrinolysis 2019; 30(1): 24–28. doi: 10.1097/MBC.0000000000000791.
- Levitt MJ, Topilow AA, Lerner W, et al. A case of FVII inhibitor. Blood 2010; 116(21): 3655. doi: 10.1182/blood.V116.21.3655.3655.
- Brewer A, Correa ME; World Federation of Hemophilia Dental Committee. Guidelines for dental treatment of patients with inherited bleeding disorders. World Federation of Hemophilia, Treatment of Hemophilia, 2006. Available from https://elearning.wfh.org/resource/guidelines-for-dental-treatment-of-patients-with-inherited-bleeding-disorders/ (accessed 23 April 2021).
- Weinstock RJ, Onyejiuwa A, Shnayder G, Clarkson EI. Use of recombinant factor VII for tooth extractions in a patient with severe congenital factor VII deficiency: a case report. J Am Dent Assoc 2015; 146(4): 271–5. doi: 10.1016/j.adaj.2014.12.022.
- Peisker A, Raschke GF, Schultze-Mosgau S. Management of dental extraction in patients with Haemophilia A and B: a report of 58 extractions. Med Oral Patol Oral Cir Bucal 2014; 19(1): e55–e60. doi: 10.4317/medoral.19191.
- Kazancıoğlu HO, Çakıir O, Gülsüm A, Zülfikar B. The effectiveness of a new hemostatic agent (Ankaferd Blood Stopper) for the control of bleeding following tooth extraction in hemophilia: A controlled clinical trial. Turk J Hematol 2013; 30: 19–24. doi: 10.4274/tjh.2012.0036.